Can a Simple Stool Swab Predict Bacteremia in High-Risk Hematopoietic Cell Transplant Recipients?

Steven A Pergam^{1

2

3}, Sanjeet S Dadwal⁴

Affiliations

¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
² Department of Medicine, University of Washington, Seattle, Washington, USA.
³ Infection Prevention, Seattle Cancer Care Alliance, Seattle, Washington, USA.
⁴ Division of Infectious Diseases, City of Hope National Medical Center, Duarte, California, USA.

Comment

Steven A Pergam et al. Clin Infect Dis. 2021.

. 2021 Oct 5;73(7):1266-1267.

doi: 10.1093/cid/ciab412.

Steven A Pergam^{1

2

3}, Sanjeet S Dadwal⁴

¹ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
² Department of Medicine, University of Washington, Seattle, Washington, USA.
³ Infection Prevention, Seattle Cancer Care Alliance, Seattle, Washington, USA.
⁴ Division of Infectious Diseases, City of Hope National Medical Center, Duarte, California, USA.

No abstract available

Keywords: fluoroquinolone; hematopoietic cell transplantation; prophylaxis; resistance; screening.

Comment on

Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, La Spina M, Gomez-Arteaga A, van Besien K, Mayer S, Phillips A, Hsu JM, Malherbe R, Small CB, Jenkins SG, Westblade LF, Kreiswirth BN, Walsh TJ. Satlin MJ, et al. Clin Infect Dis. 2021 Oct 5;73(7):1257-1265. doi: 10.1093/cid/ciab404. Clin Infect Dis. 2021. PMID: 33956965 Free PMC article.

1. Shouval R, Fein JA, Labopin M, et al. . Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European society for blood and marrow transplantation registry retrospective analysis. Lancet Haematol 2019; 6:e573–84. - PubMed
1. McDonald GB, Sandmaier BM, Mielcarek M, et al. . Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003–2007 versus 2013–2017 cohorts. Ann Intern Med 2020; 172:229–39. - PMC - PubMed
1. Mikulska M, Del Bono V, Bruzzi P, et al. . Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection 2012; 40:271–8. - PubMed
1. Hakki M, Humphries RM, Hemarajata P, et al. . Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients. Clin Infect Dis 2019; 68:2045–52. - PMC - PubMed
1. Bucaneve G, Micozzi A, Menichetti F, et al. ; Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Infection Program . Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005; 353:977–87. - PubMed